First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation (FBT) Competitors GBX 1,605.60 +45.20 (+2.90%) As of 11:33 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesBuy This Stock FBT vs. PRSM, KAPE, TRST, KNOS, LTG, ALFA, GBG, IMO, NCC, and ATGShould you be buying First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation stock or one of its competitors? The main competitors of First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation include Blue Prism Group (PRSM), Kape Technologies (KAPE), Trustpilot Group (TRST), Kainos Group (KNOS), Learning Technologies Group (LTG), Alfa Financial Software (ALFA), GB Group (GBG), IMImobile (IMO), NCC Group (NCC), and Auction Technology Group (ATG). These companies are all part of the "software - application" industry. First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation vs. Its Competitors Blue Prism Group Kape Technologies Trustpilot Group Kainos Group Learning Technologies Group Alfa Financial Software GB Group IMImobile NCC Group Auction Technology Group First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation (LON:FBT) and Blue Prism Group (LON:PRSM) are both small-cap computer and technology companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, institutional ownership, earnings, dividends, profitability, risk, valuation and analyst recommendations. Is FBT or PRSM more profitable? Company Net Margins Return on Equity Return on Assets First Trust NYSE Arca Biotechnology UCITS ETF Class A USD AccumulationN/A N/A N/A Blue Prism Group N/A N/A N/A Which has better earnings and valuation, FBT or PRSM? First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation is trading at a lower price-to-earnings ratio than Blue Prism Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioFirst Trust NYSE Arca Biotechnology UCITS ETF Class A USD AccumulationN/AN/AN/A-£1.10-1,459.64Blue Prism Group£167.30M0.00N/A-£53.80N/A Does the media prefer FBT or PRSM? In the previous week, First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation's average media sentiment score of 0.00 equaled Blue Prism Group'saverage media sentiment score. Company Overall Sentiment First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation Neutral Blue Prism Group Neutral SummaryBlue Prism Group beats First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation on 2 of the 3 factors compared between the two stocks. Get First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation News Delivered to You Automatically Sign up to receive the latest news and ratings for FBT and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding FBT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart FBT vs. The Competition Export to ExcelMetricFirst Trust NYSE Arca Biotechnology UCITS ETF Class A USD AccumulationSoftware IndustryComputer SectorLON ExchangeMarket Cap£658.64M£7.31B£29.73B£2.54BDividend YieldN/A3.77%3.18%5.30%P/E Ratio-1,459.641,210.14416.495,140.00Price / SalesN/A249.001,675.8495,247.97Price / Cash3.5417.2034.3227.93Price / BookN/A10.797.006.83Net IncomeN/A£49.83M£808.51M£5.89B7 Day Performance3.25%0.13%-0.34%-0.38%1 Month Performance6.81%2.08%3.78%45.00%1 Year Performance1.32%11.32%24,000.38%163.13% First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)FBTFirst Trust NYSE Arca Biotechnology UCITS ETF Class A USD AccumulationN/AGBX 1,605.60+2.9%N/A-1.1%£658.64MN/A-1,459.6420Gap DownPRSMBlue Prism GroupN/AN/AN/AN/A£1.24B£167.30M-23.681,025High Trading VolumeKAPEKape TechnologiesN/AN/AN/AN/A£1.22B£623.48M1,900.00850Gap DownTRSTTrustpilot Group1.6225 of 5 starsGBX 206.80-1.6%GBX 310+49.9%-5.1%£1.08B£222.55M68.55820KNOSKainos Group2.1527 of 5 starsGBX 706+1.6%GBX 1,070+51.6%-21.7%£891.76M£383.18M18.502,953News CoverageAnalyst ForecastLTGLearning Technologies GroupN/AN/AGBX 90+∞N/A£792.10M£529.20M16.755,001ALFAAlfa Financial SoftwareN/AGBX 223.50-0.2%GBX 276+23.5%+17.6%£669.34M£103.11M30.21475Gap UpGBGGB Group3.0198 of 5 starsGBX 223.50flatGBX 390+74.5%-34.4%£563.73M£276.95M-11.601,183News CoverageHigh Trading VolumeIMOIMImobileN/AN/AN/AN/A£490.40M£164.04M123.755,300NCCNCC Group1.4708 of 5 starsGBX 147.40+2.6%GBX 175+18.7%-4.5%£464.72M£326.70M-18.562,200Dividend CutATGAuction Technology Group2.4471 of 5 starsGBX 339-0.3%GBX 625+84.4%-19.4%£418.78M£136.68M41.41396Positive News Related Companies and Tools Related Companies Blue Prism Group Competitors Kape Technologies Competitors Trustpilot Group Competitors Kainos Group Competitors Learning Technologies Group Competitors Alfa Financial Software Competitors GB Group Competitors IMImobile Competitors NCC Group Competitors Auction Technology Group Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:FBT) was last updated on 9/2/2025 by MarketBeat.com Staff From Our PartnersMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | Sponsored2013 Bitcoin miner reveals his trading system (free)While everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredThe day and month stocks are most likely to crash nextGood News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history giv...Chaikin Analytics | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation Please log in to your account or sign up in order to add this asset to your watchlist. Share First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free FBT Stock Alerts